Professional Title & Qualifications:
-
Associate Chief Physician
-
M.D., Ph.D.
Specialization:
Hospital & Department：
Fudan University Shanghai Cancer Center – Department of Urology
Dr. Dalong Cao - Urologist
Personal Biography
Dr. Dalong Cao is an Associate Chief Physician in the Department of Urology at Fudan University Shanghai Cancer Center. He is a highly skilled specialist in the diagnosis and comprehensive treatment of urological malignancies, particularly prostate cancer, kidney cancer, and bladder cancer.
Dr. Cao is an expert in minimally invasive surgical techniques, including laparoscopic surgery and robotic-assisted surgery. He is dedicated to combining clinical practice with scientific research to improve patient outcomes in urologic oncology.
Book an online consultation with Dr. Dalong Cao
Areas of Expertise
-
Prostate Cancer: Early diagnosis, nerve-sparing radical prostatectomy, and comprehensive hormonal therapy.
-
Kidney Cancer (Renal Cell Carcinoma): Nephron-sparing surgery (partial nephrectomy) and minimally invasive treatments for metastatic renal cancer.
-
Bladder Cancer: Radical cystectomy and bladder cancer preservation strategies.
-
Robotic Surgery: Proficient in Da Vinci robotic surgery and the novel Carina robotic platform for complex urological procedures.
-
Minimally Invasive Surgery: Advanced laparoscopic techniques for urological tumors.
Clinical Highlights
-
Over 5,300 patients treated
-
100% treatment satisfaction rate
-
100% patient satisfaction with service attitude
Work Experience
-
Associate Chief Physician Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
-
Researcher Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
-
Resident / Attending Physician Department of Urology, Fudan University Shanghai Cancer Center (Previous positions).
Scientific Research & Achievements
-
Clinical Innovation: Conducted the first reported clinical outcomes using the Carina Robotic Platform for urologic procedures, demonstrating feasibility and safety in Robot-Assisted Radical Prostatectomy (RARP) and Partial Nephrectomy (RAPN).
-
Genomic Research: Investigated the genomic landscape of Upper Tract Urothelial Carcinoma (UTUC) in Chinese patients to aid in precise diagnosis and treatment.
-
Molecular Mechanisms: Published research on the PRUNE2 gene mutation and its influence on prostate cancer cell proliferation and migration.
-
Circular RNAs: Studied the function and mechanisms of circular RNAs in urologic cancers.
-
Drug Resistance Studies: Researched mechanisms to overcome gemcitabine resistance in bladder cancer through iron modulation.
-
Publications: Regularly publishes academic papers in reputable journals such as Journal of Cancer, BJUI Compass, Cancer Research, and JCO Precision Oncology.
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.